CannaPharmaRx has secured new genetic strains of cannabis for its declaration. This declaration gets submitted to Health Canada and will allow the new strains to be sold to other licensed producers. The company anticipates this to be one of the final steps before its first harvesting, likely during the first quarter.
The declaration, which is submitted in conjunction with receiving a standard cultivation license, will allow the company to grow in excess of 200 separate strains. The genetics have been carefully selected from one of Canada's premier master growers, who is employed by the company.
"This will result in some of the most desirable genetics in the country being available to CannaPharmaRx. We hope to grow and harvest one of the most heavily demanded product lines available. It is our goal to start distributing product during the next quarter," said Nick Colvin, CEO of CannaPharmaRx.
For more informaiton: